mesoblast (asx:msb, nasdaq:meso): breakthrough treatment of covid-19 targeted by ryoncil
Published 4 years ago • 6.1K plays • Length 14:42Download video MP4
Download video MP3
Similar videos
-
21:49
mesoblast (asx: msb) – webinar presentation
-
11:18
mesoblast
-
18:47
mesoblast
-
14:51
mesoblast
-
18:47
mesoblast
-
4:10
coronavirus treatment: mesoblast has developed promising cellular therapy treatment
-
17:42
mesoblast (asx:msb) - webinar presentation
-
5:08
mesoblast talks development of cell-based medicines
-
1:21
medicine company mesoblast a top performer in asx200 and a step closer to us approval
-
14:14
mesoblast
-
5:54
mesoblast (asx:msb) talks disruptive cellular medicines
-
14:17
mesoblast
-
13:31
mesoblast
-
13:17
mesoblast
-
10:29
mesoblast: edison open house healthcare 2022
-
0:50
mesoblast set to merge with angioblast
-
1:30
medishield life: coverage for all, for life
-
15:33
mesoblast
-
3:53:29
virtual macs covid-19 day 2020